Shen et al. [21] analysed the plasma concentrations of 375 metabolites in six patient subgroups categorized by BC type (hormone receptor-positive and TNBC), ethnicity (African American and Caucasian American), and disease status (case and control). This evidence concerns the gene NR4A1 and breast cancer.